Empowering Women’s Health Through Diagnostic Testing

Women’s Health Testing

Diagnostic testing plays a crucial role in detecting and managing conditions such as bacterial vaginosis, vaginitis, HPV, and Group B Streptococcus for holistic well-being.

Diagnostic testing in women’s health plays a pivotal role in identifying and addressing a range of gynecological and reproductive issues. Accurate diagnosis is paramount to ensure proper treatment and prevent complications. From bacterial vaginosis (BV) to vaginitis, human papillomavirus (HPV) infections, and Group B Streptococcus (GBS) screening, these tests provide invaluable insights guiding medical professionals in delivering effective care.

Bacterial Vaginosis Diagnostic Testing

Bacterial vaginosis, a common vaginal infection, affects about 29% of women in the United States between the ages of 14 and 49. Accurate diagnosis is crucial to ensure appropriate treatment. A pH test and “whiff test” are common initial steps, followed by microscopic examination of vaginal discharge for “clue cells” coated with bacteria.

Vaginitis Diagnostic Testing

Vaginitis, characterized by vaginal tissue inflammation, affects millions of women each year in the United States. Accurate diagnosis is essential as different causes of vaginitis require distinct treatments. Microscopic examination or culturing of vaginal discharge helps identify yeast cells, trichomonads, and clue cells.

HPV Diagnostic Testing

Human papillomavirus (HPV) testing is pivotal in women’s health screenings. High-risk HPV DNA detection in cervical cells, often coupled with a Pap smear, provides a comprehensive assessment of cervical health. The American Cancer Society underscores the importance of regular HPV testing and Pap smears for early detection and prevention of cervical cancer. HPV is the most common sexually transmitted infection, and about 79 million Americans are currently infected with HPV.

Group B Streptococcus (GBS) Screening

Group B streptococcus, a bacterium present in the vagina or rectum, can pose risks to newborns during childbirth. The CDC recommends GBS testing “between the 35th and 37th week of pregnancy”. Swabs of the vagina and rectum are collected and sent for culture. Timely GBS screening is essential to safeguard newborns from potential infections.

Diagnostic testing in women’s health management is a comprehensive approach to overall well-being. By unraveling insights into conditions like bacterial vaginosis, vaginitis, HPV infections, and GBS, these tests empower medical practitioners to tailor treatments for individual patients. With accurate diagnosis and early intervention, women can lead healthier lives.

Vaginitis refers to the inflammation of the vaginal tissue and can be caused by various factors, including:
  • 1

    Bacterial Vaginosis (BV)

  • 2

    STIs

  • 3

    Yeast Infections

  • 4

    Trichomoniasis

  • 5

    Irritant or Allergic Reactions

  • 6

    Hormonal Changes

  • 7

    Foreign Bodies

Women’s Health Sample Report

Panel Details

Women’s Health

  • Human papillomavirus type 18, Human papillomavirus type 45
  • Streptococcus agalactiae (Group B Strep)
  • Candida auris, Candida glabrata
  • Candida albicans, C.tropicalis, C. parapsilosis, C. dubliniensis
  • Human papillomavirus type (HPV 52,59,66,68)
  • Human papillomavirus type (HPV31,33,39
  • Mycoplasma genitalium, Mycoplasma hominis
  • HSV1
  • HSV2
  • Chlamydia trachomatis
  • Gardnerella vaginalis
  • Candida krusei
  • Prevotella bivia
  • Megasphera 1
  • Megasphera 2
  • Haemophilus ducreyi
  • Neisseria gonorrhoeae
  • Atopobium vaginae, BVAB2, Mobiluncus curtisii, Mobiluncus mulieris
  • Human papillomavirus type 16
  • Treponema pallidum
  • Trichomonas vaginalis
  • Ureaplasma urealyticum, parvum
  • Viridans Group Strep
  • mefA/cfr
  • Macrolide 1
  • Atopobium vaginae, BVAB2, Mobiluncus curtisii, Mobiluncus mulieris
  • Megasphera 1
  • Megasphera 2
  • Gardnerella vaginalis
  • Streptococcus agalactiae (Group B Strep)
  • Enterococcus faecalis, Enterococcus faecium
  • Escherichia coli
  • Staphylococcus aureus
  • qnrA/qnrS
  • act/fox/acc/kpc
  • tem/shv/act/ant
  • oxa48/ctxM/ges
  • blaPER/blaVEB
  • imp/ndm/vim
  • Vancomycin
  • DFR A1/A5, SUL 1/2
  • Methicillin 1
  • blaPER/blaVEB
  • Prevotella bivia
  • Megasphera 1
  • Megasphera 2
  • Atopobium vaginae, BVAB2, Mobiluncus curtisii, Mobiluncus mulieris
  • Gardnerella vaginalis
  • Candida krusei
  • Candida albicans, C.tropicalis, C. parapsilosis, C. dubliniensis
  • Candida auris, Candida glabrata
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Ureaplasma urealyticum, parvum
  • Mycoplasma genitalium, Mycoplasma hominis
  • Trichomonas vaginalis
  • mefA/cfr
  • Macrolide 1
  • Gardnerella vaginalis
  • Mycoplasma genitalium, Mycoplasma hominis
  • Candida group 1 (Candida albicans, C.tropicalis, C. parapsilosis, C. dubliniensis)
  • Candida group 2 (Candida auris, Candida glabrata)
  • Trichomonas vaginalis
  • Macrolide 1
  • mefA/cfr
  • Chalmydia trachomatis
  • Neisseria gonorrhoeae
  • HSV1
  • HSV2
  • Human papillomavirus type 16
  • Human papillomavirus type 18, Human papillomavirus type 45
  • Human papillomavirus type (HPV31,33,39)
  • Human papillomavirus type (HPV 52, 59,68)
  • Haemophilus ducreyi
  • Treponema pallidum
  • Chalmydia trachomatis
  • HSV1
  • HSV2
  • Human papillomavirus type 16
  • Human papillomavirus type 18
  • Human papillomavirus type 45
  • Human papillomavirus type (HPV31,33,39)
  • Human papillomavirus type (HPV 52, 59,68)
  • Streptococcus agalactiae (Group B Strep)
  • Streptococcus agalactiae (Group B Strep)
  • Escherichia coli
  • Enterococcus faecalis, Enterococcus faecium
  • Staphylococcus aureus
  • qnrA/qnrS
  • act/fox/acc/kpc
  • tem/shv/act/ant
  • oxa48/ctxM/ges
  • blaPER/blaVEB
  • imp/ndm/vim
  • Vancomycin
  • DFR A1/A5, SUL 1/2
  • Methicillin 1